Idorsia | Results Day Center

Search

Search
Share
Share
Facebook

Twitter

LinkedIn

Mail
Location

Location
Contact
Contact
General Contact

General Contact:

Idorsia Pharmaceuticals Ltd
Hegenheimermattweg 91
4123 Allschwil
Switzerland

+41 58 844 00 00

Please get in touch with us via the contact form by clicking "Next".

For patients and healthcare professionals

Investor Relations

Media Relations

Business Development

Whistleblower hotline

Whistleblower hotline:

Switzerland: 0800 110 007

USA: (833) 222-3891 (anonymous reporting channel)

Outside Switzerland and USA: +41 58 844 0106

Learn more about our Governance by clicking "Next"

Data Protection Officer

Data Protection Officer:

Idorsia attempts to ensure that your Personal Data are updated, accurate, and complete according to the information that has been provided. Any request related to the exercise of your privacy rights can be sent through the link below.

Webmaster

Stay informed

Stay informed:

To best serve your interest, Idorsia offers an electronic ‘Stay Informed’ service. With this service you have the possibility to automatically receive Idorsia's Media Releases directly to your inbox. In addition, if you provide your mobile phone number, we will send you an alert via SMS when the media release is published.

Results day center

Results day center

Investor community: To make your job easier the Results Day Center is your one-stop-shop for all relevant documentation for our quarterly financial reporting.
Equity story

Equity story

Investor community: Idorsia represents a unique opportunity, with all the key ingredients to reach out for more! In this section you will find information about our ambitious goals.
Financial information

Financial information

Investor community: Get all the details on our curent financial situation as well as supporting archive financial information.
Corporate reports

Corporate reports

Investor community: Providing comprehensive and timely information to our shareholders is important to us. You can find a full archive of our corporate reports on this page.
News and events
News and events

Investor community: Get an overview of when we have the next financial reporting, most recent media releases, and an archive of our investor webcasts.
Stock information
Stock information

The registered shares of Idorsia Ltd were listed on the SIX Swiss Exchange on June 16, 2017 (symbol: IDIA). Following the transfer of Actelion’s drug discovery and early-stage clinical pipeline business to Idorsia, registered Idorsia shares held by Actelion have been distributed to Actelion shareholders by way of a dividend in kind.
Governance

Governance

Investor community: Sound corporate governance and high standards of ethical behavior are essential to company success, learn more about our approach to corproate governance and sustainability.

Idorsia announced its financial results for the first nine months of 2024 on Tuesday, October 29, 2024. Find all relevant information on this page.

Media Release

9M 2024 financial reporting media release

Financial Report

9M 2024 Financial Report

Updated corporate documents

Contact

Investor Relations

Andrew Weiss

+41 58 844 10 10
Contact us online

General Contact:

Whistleblower hotline:

Data Protection Officer:

Stay informed:

Results day center

Equity story

Financial information

Corporate reports

News and events

Stock information

Governance

Results Day Center

Media Release

Financial Report

Updated corporate documents

Contact

Updated content